Safety, Pharmacodynamics, and Efficacy of NXT007 After Switching from Emicizumab in Hemophilia A with and without inhibitors (NXTAGE Part C)

Feb 6, 2026 — 09:42 am - 9:51 AM
The Auditorium

Main Session

Parent session

8:30 AM10:00 AM

Session 7: SLAM

Ruth GILMOREUniversity Hospital GalwayPratima CHOWDARY MAMILLAPALLI-